Crowdfunding for Immunotherapy Treatment in India — What Actually Works, and What Doesn't

Sometimes, and far less predictably than the success stories suggest. Crowdfunding works best as a top-up for a gap you have already narrowed, not as the whole funding plan. What a campaign raises tracks the reach of your own network, not the severity of the diagnosis. All figures here are indicative, as of August 2026.

Almost everything written about medical crowdfunding is written by the platforms themselves, and it is written around the campaigns that worked. The campaigns that quietly closed at a fifth of their target are not on anyone's homepage. Published analyses of medical crowdfunding, most of them from outside India, point consistently in the same direction: a large share of campaigns raise well under the amount they asked for, and a small number of highly shared campaigns collect most of the money on any given platform. Nothing about Indian platforms suggests a different shape.

That is not a reason to avoid it. It is a reason to size it correctly. A family that has already tested its scheme entitlement, asked the hospital welfare desk for a concession, and had an honest conversation with the treating oncologist about a CDSCO-approved biosimilar is usually asking the internet for a much smaller and much more winnable number than a family that starts here.

What actually decides whether a campaign works

• How many people will share it in the first 48 hours. Medical campaigns are front-loaded. Most of what a campaign will ever raise arrives in the first few days, from people who already know the family. If you cannot name twenty to thirty people who will post it the day it goes live, the campaign is not ready to launch.
• Whether the ask is a specific gap or an open-ended total. "We need eleven lakh for treatment" performs worse than "we have arranged this much, this is what is left for the next four cycles, here is the doctor's estimate." A defensible number with a document behind it is easier to give to.
• Whether the family is willing to be public. A campaign is a permanent, searchable, public statement of a cancer diagnosis with photographs and a bill attached. That is a real cost, it falls hardest on the patient, and it cannot be undone once shared. Decide it as a family before you write a word.
• Whether the paperwork is complete on day one. Platforms verify documents before a campaign goes live and again before releasing money. An incomplete file delays both ends, and the delay usually lands in the week you needed the money.
• Whether anyone is updating it. Campaigns that post scan updates, receipts and thank-yous keep receiving money. Campaigns that go silent after week one stop, almost without exception.

Indian families mostly use Ketto, Milaap, ImpactGuru and Give.do, or raise money through an NGO or a hospital-linked appeal. Every route deducts something. Platform fees commonly sit between zero and about five per cent, gateway charges around two to three per cent, and GST applies on those fees. Indicative, as of August 2026.

Comparing platforms comes down to four numbers on one page: the platform fee, whether a zero-platform-fee plan exists and who funds it, the payment-gateway charge, and whether GST is added on those fees. For medical campaigns most platforms prefer to release money to the treating hospital against bills rather than into a personal account, which is a protection for the donor and an administrative step for you. Ask how it works before you launch, not on the day you need the money.

The diagnosis pack, a dated written treatment estimate on hospital letterhead, photo identity and PAN for both patient and organiser, and the hospital's registration and account details. Platforms verify these before the campaign goes live and again before releasing money. Assemble one set and reuse it everywhere.

1. 1

   Build the diagnosis pack first

   Biopsy or histopathology report, imaging reports, and the treating oncologist's clinical summary naming the diagnosis and stage. Every platform verifies against documents, never against a phone call. Scan the whole set once and keep it on a phone, because you will be asked for it again at withdrawal.

2. 2

   Ask for a written treatment estimate on letterhead

   It should state the treatment planned, the number of cycles planned and an indicative total, with a date on it. This is the document that turns a round number into a defensible ask. Treat the figure as indicative, because a plan can change if the disease responds differently or if a side effect needs managing.

3. 3

   Get identity and PAN in order for two people

   The patient and the campaign organiser both need photo identity, and PAN is normally required for the person withdrawing. Check that the name is spelled identically across Aadhaar, PAN, the hospital file and the bank account. A spelling mismatch is the commonest avoidable delay in the entire process.

4. 4

   Expect the money to go to the hospital

   For medical campaigns most platforms prefer to release funds to the treating hospital against bills rather than into a personal account. Ask the hospital's billing or welfare desk for the standard set of registration and account details they issue for this purpose, and keep every receipt and discharge summary.

5. 5

   Decide as a family what becomes public

   A campaign puts a name, a photograph, a diagnosis and often a bill into public search results permanently. The patient should have the final say, not the person doing the fundraising. Agree in advance what will not be shared, and write the campaign so it can be read by a colleague or a neighbour without the patient feeling exposed.

6. 6

   Set a target you can justify with a document

   Ask for the gap that remains after schemes, concessions and what the family can arrange — not the lifetime cost of treatment. State plainly what the money buys, over what period, and what happens to anything left over. An ask tied to a doctor's estimate converts better than a large round figure with nothing behind it.

7. 7

   Line up the first 48 hours before you publish

   Write to twenty or thirty people privately, tell them the campaign goes live on a named day and ask them to share it that day. Prepare the message they will forward. Then keep posting updates weekly. Campaigns that go quiet after the first week stop receiving money, almost without exception.

Expect a single-digit percentage of everything pledged to be deducted before release. At a five per cent platform fee, a two and a half per cent gateway charge and GST on those fees, deductions come to roughly nine per cent. About ninety-one thousand rupees of a one lakh rupee campaign reaches the hospital. Indicative, as of August 2026.

What a campaign realistically raises

Nobody can tell you the number, and any platform that implies it can is selling you something. What can be said honestly is the shape of it. Totals are skewed: a few campaigns raise a great deal and most raise modestly. The money arrives in a steep curve, heavy in the first three or four days and thin afterwards. It comes overwhelmingly from people the family already knows, which means the realistic ceiling is set by the size and the financial capacity of that circle. A campaign shared into a large, salaried, urban network behaves very differently from one shared into a small rural one, with the same diagnosis and the same photographs.

The practical consequence is a planning rule. Do not commit to a treatment schedule on the assumption that a campaign will reach its target. Tell the treating oncologist that a campaign is running and what it has raised so far, so the clinical plan and the funding plan are held by the same team, and ask plainly what is safe to defer and what is not. If the money is already running short mid-treatment, that conversation is more urgent, not less — what happens if you run out of money mid-treatment sets out what to say and in what order.

Narrow the gap before you publicise it. Every rupee removed by a scheme, a concession, a biosimilar discussion or a tax claim is a rupee you do not have to raise, and it makes the remaining ask far more winnable. Work through these in the same week.

• Go to the hospital welfare desk on day one. It is a different counter from billing. They know what concessions exist internally, which local trusts are active this year, and which relief funds the institution can actually receive money from. Families skip this desk more often than any other, and it is usually the fastest route of all.
• Test the scheme route and keep the answer in writing. Ask the Aarogyasri Mithra desk at an empanelled hospital, or the PM-JAY desk, to check the current package list against the exact regimen on the prescription. A refusal letter is useful — several relief funds and NGOs want to see the scheme entitlement has been tested. See Ayushman Bharat and immunotherapy and whether health insurance covers immunotherapy in India.
• Ask your oncologist about a CDSCO-approved biosimilar. Where one exists and is clinically appropriate, the same drug class can cost materially less. It remains a clinical decision for the treating team and never a purchasing decision made on price alone. How much biosimilars actually save explains what is and is not settled.
• Ask whether a clinical trial is open and appropriate. Trials are informational, not something anyone can promise you a place in, and an investigational treatment carries no assurance of benefit. But it is a legitimate question to ask the treating team. Can you get immunotherapy free through a clinical trial sets out how that works.
• Apply to the relief funds in parallel, not in sequence. Central and state relief funds, NGO grants and manufacturer assistance programmes all run on their own timelines and there is no penalty for filing widely. Government and NGO funding routes for immunotherapy lists them with the paperwork each asks for.
• Compare the estimate before you fundraise against it. Two written estimates for the same regimen can differ meaningfully, and a campaign built on the higher one asks your network for money it did not need to. Comparing immunotherapy costs between centres lists what to check line by line, and the hidden costs of immunotherapy covers what estimates routinely leave out.
• Claim what the law already allows. Tax relief on treatment costs is not fundraising, but it is money back. Section 80DDB and tax relief on immunotherapy costs covers who can claim it and what certificate is needed.

Crowdfunding is the last lever, not the first. These companion pages cover the reliefs you can claim, how to fund treatment from another country, how to check whether an estimate is fair, and how the whole pathway fits together at CION.

• Section 80DDB and Tax Relief on Immunotherapy Costs — who can claim, what certificate the assessing officer expects, and where families lose the deduction on a technicality.
• Paying for a Parent's Immunotherapy From Abroad — the practical route for an NRI son or daughter funding treatment in India, and the rules that apply to the transfer.
• Comparing Immunotherapy Costs Between Centres: What to Check — how to read two estimates against each other line by line, so you fundraise for the right number.
• Questions to Ask Before Paying for Any Immune Treatment — the checks worth running before money changes hands, on any treatment described as immune-based.
• Immunotherapy at CION Cancer Clinics — how eligibility review, day-care treatment and cost counselling fit together as a single pathway.

Decisions for Healing, Not Billing

Every plan goes to a tumour board, and every family gets the cost picture in writing before treatment starts.